Animal Drugs, Feeds, and Related Products; Piperazine Adipate Powder, Diprenorphine Hydrochloride Injection, Etorphine Hydrochloride Injection, and Certain Nitrofuran and Buquinolate Products
other · Food and Drug Administration · Rule · Published 1995-08-04 · Effective 1995-08-14 · 60 FR 39846
Document
Document number
95-19091
Federal Register citation
60 FR 39846
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1995-08-04
Effective date
1995-08-14
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions reflecting approval of 16 new animal drug applications (NADA's) held by Proctor & Gamble Pharmaceuticals, Inc., Happy Jack, Inc., and Lemmon Co. The NADA's provide for the use of piperazine adipate powder, diprenorphine hydrochloride (diprenorphine HCl) injection, etorphine HCl injection, certain nitrofuran dosage form products, and separately approved Type A medicated articles containing buquinolate or certain other drugs in manufacturing several Type C medicated feeds for chickens. In a notice published in the July 21, 1995, issue of the Federal Register, FDA is withdrawing approval of the NADA's.